LncRNA LUCAT1 as a prognostic biomarker in cholangiocarcinoma through targeting miR-141-3p: clinical and functional insights
LUCAT1 demonstrates significant diagnostic and prognostic potential and could serve as a novel biomarker for CHOL.
Authors
- Niu Zhang
- Chengcheng Ying
- Shanshan Zhou (ORCID: https://orcid.org/0000-0003-4466-803X)
- Zouxiao Hu
- Qing Chen (ORCID: https://orcid.org/0000-0002-1828-7797)
- Guanbao Long
- Youcai An (ORCID: https://orcid.org/0009-0008-4507-1538)
- Jiangyang Sun
Institutions
- Jiangsu University (CN)
- Central Hospital of Wuhan (CN)
- Shenzhen Third People’s Hospital (CN)
- Wuhan University of Science and Technology (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Hereditas
- Published
- 2025-07-26
- DOI
- https://doi.org/10.1186/s41065-025-00512-6
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00